Renato Mantegazza

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis

Ezio Gerdoni, Barbara Gallo, Simona Casazza et al. · Annals of Neurology · 2007 · 483 citations · Full text

Life Sciences, Immunology, Neuroscience +16

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

Paraskevi Zisimopoulou, Panagiota Evangelakou, John Tzartos et al. · Journal of Autoimmunity · 2013 · 324 citations · Full text

Life Sciences, Endocrinology, Immunology +11

An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis

Donald B. Sanders, I. K. Hart, Renato Mantegazza et al. · Neurology · 2008 · 313 citations

Medicine, Pharmacology, Pharmacotherapy +15